β受体阻滞药卡维地洛

被引：6

作者：

周斌

魏尔清

机构：

[1] 浙江医科大学药理学教研室

[2] 浙江医科大学药理学教研室杭州

[3] 杭州

来源：

中国新药杂志 | 1996年 / 01期

关键词：

卡维地洛; β受体阻滞药; 高血压; 心绞痛; 充血性心力衰竭;

D O I：

暂无

中图分类号：

R972 [心血管系统药物];

学科分类号：

1007 ;

摘要：

卡维地洛有β1和α1受体阻滞,以及钙拮抗作用。可扩张血管,保护心肌和神经元,并具有药效持续时间长、副作用少等优点。可用于高血压、心绞痛、充血性心力衰竭的治疗。本文简介了卡维地洛的药代动力学过程、药理作用和临床应用。

引用

页码：23 / 26

页数：4

共 8 条

[1] CARVEDILOL INHIBITS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION [J].

SUNG, CP ;

ARLETH, AJ ;

OHLSTEIN, EH .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (02) :221-227

[2]

Neuroprotective Effects of Carvedilol, a New Antihypertensive Agent, in Cultured Rat Cerebellar Neurons and in Gerbil Global Brain Ischemia[J] . Paul G. Lysko,Kathryn A. Lysko,Tian-Li Yue,Christine L. Webb,Juan-Li Gu,Giora Feuerstein.Stroke . 1992 (11)

[3] EFFECTS OF CARVEDILOL ON ADRENERGIC-RECEPTOR PHARMACOLOGY IN HUMAN VENTRICULAR MYOCARDIUM AND LYMPHOCYTES [J].

BRISTOW, MR ;

LARRABEE, P ;

MULLERBECKMANN, B ;

MINOBE, W ;

RODEN, R ;

SKERL, L ;

KLEIN, J ;

HANDWERGER, D ;

PORT, JD .

CLINICAL INVESTIGATOR, 1992, 70 (02) :S105-S113

[4]

Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation[J] . R. R. Ruffolo,C. F. Sauermelch,R. N. Willette.European Journal of Clinical Pharmacology . 1990 (2)

[5]

Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension[J] . J. P. Ollivier,P. Durier,J. L. Bussiere,J. L. Gayet.European Journal of Clinical Pharmacology . 1990 (2)

[6]

Effect of Carvedilol on Ambulatory Blood Pressure, Renal Hemodynamics, and Cardiac Function in Essential Hypertension[J] . Alain G. Dupont,Patricia Van der Niepen,Yves Taeymans,Michel Ingels,Amon Piepsz,Axel M. Bossuyt,Pierre Block,Roland O. Six,Marc H. Jonckheer,Luc Vanhaelst.Journal of Cardiovascular Pharmacology . 1987 (11 S)

[7]

Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker[J] . European Journal of Clinical Pharmacology . 1987 (5)

[8]

Pharmacokinetics and bioavailability of carvedilol in patients with liver cirrhosis. Neugebauer G, Gabor M, Reiff K. Drugs . 1988

← 1 →